|
Volumn 147, Issue 5, 2014, Pages 1146-1148
|
American gastroenterological association institute guideline on the pharmacological management of irritable bowel syndrome
a b c d,e |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALOSETRON;
LAXATIVE;
LINACLOTIDE;
LOPERAMIDE;
LUBIPROSTONE;
RIFAXIMIN;
SEROTONIN UPTAKE INHIBITOR;
SPASMOLYTIC AGENT;
TRICYCLIC ANTIDEPRESSANT AGENT;
GASTROINTESTINAL AGENT;
ABDOMINAL PAIN;
BLOATING;
DIARRHEA;
DRUG COST;
FOLLOW UP;
HUMAN;
IRRITABLE COLON;
MEDICAL SOCIETY;
PRACTICE GUIDELINE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
SYSTEMATIC REVIEW (TOPIC);
COMPLICATION;
CONSTIPATION;
DRUG COMBINATION;
ECONOMICS;
EVIDENCE BASED MEDICINE;
GASTROENTEROLOGY;
IRRITABLE BOWEL SYNDROME;
STANDARDS;
TREATMENT OUTCOME;
UNITED STATES;
CONSTIPATION;
DRUG COSTS;
DRUG THERAPY, COMBINATION;
EVIDENCE-BASED MEDICINE;
GASTROENTEROLOGY;
GASTROINTESTINAL AGENTS;
HUMANS;
IRRITABLE BOWEL SYNDROME;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 84908277873
PISSN: 00165085
EISSN: 15280012
Source Type: Journal
DOI: 10.1053/j.gastro.2014.09.001 Document Type: Article |
Times cited : (90)
|
References (4)
|